Compounds > 1,3-dipropyl-8-cyclopentylxanthine
Page last updated: 2024-10-21

1,3-dipropyl-8-cyclopentylxanthine and Sciatica

1,3-dipropyl-8-cyclopentylxanthine has been researched along with Sciatica in 1 studies

DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.

Sciatica: A condition characterized by pain radiating from the back into the buttock and posterior/lateral aspects of the leg. Sciatica may be a manifestation of SCIATIC NEUROPATHY; RADICULOPATHY (involving the SPINAL NERVE ROOTS; L4, L5, S1, or S2, often associated with INTERVERTEBRAL DISK DISPLACEMENT); or lesions of the CAUDA EQUINA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wu, WP1
Hao, JX1
Halldner, L1
Lövdahl, C1
DeLander, GE1
Wiesenfeld-Hallin, Z1
Fredholm, BB1
Xu, XJ1

Other Studies

1 other study available for 1,3-dipropyl-8-cyclopentylxanthine and Sciatica

ArticleYear
Increased nociceptive response in mice lacking the adenosine A1 receptor.
    Pain, 2005, Volume: 113, Issue:3

    Topics: Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Analgesics, Opioid; Analysis of V

2005